Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01864070
Recruitment Status : Withdrawn
First Posted : May 29, 2013
Last Update Posted : July 22, 2014
Sponsor:
Collaborators:
BTG International Inc.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : May 2018
  Study Completion Date : No date given